首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis
Authors:Dr Jiezhong Chen  Ross Crawford  Yin Xiao
Institution:1. Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland 4059, Australia;2. Illawarra Health and Medical Research Institute, University of Wollongong, Northfields Avenue, New South Wales 2522, Australia
Abstract:Osteoarthritis is characterized by degenerative alterations of articular cartilage including both the degradation of extracellular matrix and the death of chondrocytes. The PI3K/Akt pathway has been demonstrated to involve in both processes. Inhibition of its downstream target NF‐kB reduces the degradation of extracellular matrix via decreased production of matrix metalloproteinases while inhibition of mTOR increased autophagy to reduce chondrocyte death. However, mTOR feedback inhibits the activity of the PI3K/Akt pathway and inhibition of mTOR could result in increased activity of the PI3K/Akt/NF‐kB pathway. We proposed that the use of dual inhibitors of PI3K and mTOR could be a promising approach to more efficiently inhibit the PI3K/Akt pathway than rapamycin or PI3K inhibitor alone and produce better treatment outcome. J. Cell. Biochem. 114: 245–249, 2013. © 2012 Wiley Periodicals, Inc.
Keywords:OSTEOARTHRITIS  EXTRACELLULAR MATRIX METALLOPROTEINASES  AUTOPHAGY  PI3K/Akt PATHWAY
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号